Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia-reperfusion injury by 3',4'-dihydroxyflavonol. [electronic resource]
Producer: 20160426Description: 53-9 p. digitalISSN:- 1879-0712
- Animals
- Cardiotonic Agents -- pharmacology
- Chromones -- therapeutic use
- Drug Therapy, Combination
- Female
- Flavonoids -- therapeutic use
- Flavonols -- pharmacology
- MAP Kinase Signaling System -- drug effects
- Morpholines -- therapeutic use
- Myocardial Infarction -- drug therapy
- Myocardial Reperfusion Injury -- drug therapy
- Myocytes, Cardiac -- drug effects
- Phosphatidylinositol 3-Kinases -- drug effects
- Primary Cell Culture
- Prodrugs -- pharmacology
- Proto-Oncogene Proteins c-akt -- drug effects
- Rats
- Sheep
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.